541 related articles for article (PubMed ID: 15589562)
1. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
Khan A; Brodhead AE; Kolts RL; Brown WA
J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
[TBL] [Abstract][Full Text] [Related]
2. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
Niklson IA; Reimitz PE; Sennef C
Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
[TBL] [Abstract][Full Text] [Related]
4. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
5. Placebo response and antidepressant clinical trial outcome.
Khan A; Detke M; Khan SR; Mallinckrodt C
J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
[TBL] [Abstract][Full Text] [Related]
6. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
7. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis.
Chen Y; Guo JJ; Zhan S; Patel NC
Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.
Zhang ZJ; Tan QR; Tong Y; Li Q; Kang WH; Zhen XC; Post RM
J Affect Disord; 2008 Jul; 109(1-2):91-7. PubMed ID: 18093662
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
13. A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.
Wilcox CS; Ferguson JM; Dale JL; Heiser JF
Psychopharmacol Bull; 1996; 32(3):335-42. PubMed ID: 8961776
[TBL] [Abstract][Full Text] [Related]
14. Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?
Evans KR; Sills T; Wunderlich GR; McDonald HP
J Psychiatr Res; 2004; 38(4):437-44. PubMed ID: 15203296
[TBL] [Abstract][Full Text] [Related]
15. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
16. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
17. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
18. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
19. Impact of study design on the results of continuation studies of antidepressants.
Zimmerman M; Posternak MA; Ruggero CJ
J Clin Psychopharmacol; 2007 Apr; 27(2):177-81. PubMed ID: 17414242
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
